David Setboun, EVP and COO at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 5,000 shares at $12.95 ($65K) on 2020-07-16, disclosed to the SEC on 2020-07-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.